RowDiagnosed 2026-10-11 08:45:43 KSTEETONAI Stock Diagnostic ReportEton Pharmaceuticals CBO David Krempa sells $229k in stockThe fact that David Krempa, Chief Business Officer (CBO) of Eton Pharmaceuticals, sold approximately $229,000 worth of company stock can be interpreted as a negative signal.View Source Article ↗ AI CATALYST SCORE30 / 100Score computed by Sentinel V12REFERENCE PRICENot measuredReference entry price at analysis time 👍 0🔥 0🤔 0🔗 0𝕏f🔗📤